Idea for Chemomab Therapeutics Ltd.: - 131% borrow fee for shares. 47 shares available for borrow, according to iborrowdesk. - Bottom of Risk Range: - S3 Filing Sales Agreement with Cantor Fitzgerald & Co. dated Apr 30, 2021. fintel.io - Cantor Fitzgerald assigned overweight rating on CMMB and raised price target to $45. www.marketbeat.com - Good short squeeze...